SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Shasun informs about press release

01 Nov 2016 Evaluate

Strides Shasun has informed about a Press Release dated November 01, 2016, titled ‘Strides Shasun receives USFDA Approval For Abacavir Tablets’.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

1060.10 -10.80 (-1.01%)
24-Apr-2026 09:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1638.00
Dr. Reddys Lab 1318.20
Cipla 1285.60
Zydus Lifesciences 930.95
Lupin 2316.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×